Clinical Trial Update: The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating DWP16001 in combination with metformin for type 2 diabetes patients inadequately controlled on metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• DWP16001 (in combination with metformin) (DWP16001)
• metformin (metformin)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 3 | Status: ACTIVE_NOT_RECRUITING